Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New EU project looking at late side-effects of the treatment of childhood cancer

06.11.2013
Coordination by the Mainz University Medical Center / European Union provides funding of approximately EUR 6 million

Is it possible to predict the likelihood of subsequent complications following cancer treatment on the basis of genetic tests? This is the main question to be addressed by an EU-wide research project that is being coordinated by the German Childhood Cancer Registry at the Institute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI) of the Mainz University Medical Center.

The project will focus on late effects of the childhood tumor therapy, such as fertility problems and hearing loss. In addition, the researchers aim to determine the overall effect of these complications on the health-related quality of life of former patients. The European Union will be providing funding of some EUR 6 million to support the research project entitled PanCareLIFE.

The prognosis for survival of patients who develop cancer as children has significantly improved in the last decades. Depending on the diagnosis, some 80 percent of those afflicted now experience remission. However, the improvement in the rate of long-term survival has also resulted in an increase of the rate of those likely to suffer late complications. These complications can take various forms, such as damage to organs (e.g., heart, kidneys, ear), impairment of the quality of life (due to growth problems, physical disabilities, intellectual impairment, or difficulty with social integration), and an increased risk of second cancer.

Researchers from eight European countries, i.e., the Czech Republic, Denmark, France, Germany, Ireland, Italy, the Netherlands, and Switzerland, will be participating in the PanCareLIFE project. The data from a total of about 12,000 former patients from all participating countries will be analyzed. The researchers involved hope to be able to use this data to identify genetic and non-genetic risk factors that may be associated with fertility problems and deafness. They thus intend to study genetic material in order to determine which genetic variants may be associated with the above-mentioned complications. The data collected during the PanCareLIFE project will be collated centrally at the German Childhood Cancer Registry of IMBEI at the Medical Center of Johannes Gutenberg University Mainz (JGU).

"It is a great honor for us that we here in Mainz at IMBEI have been assigned the coordination of this project and the responsibilities for collation of this valuable European data and the main statistical analysis," said PD Dr. Peter Kaatsch, Project Coordinator and Head of the German Childhood Cancer Registry. Professor Maria Blettner, Director of IMBEI, added: "The fact that we have improved the rate of long-term cancer survival is a great achievement. At the same time, this necessarily means that we need to focus on the possible late complications. PanCareLIFE can make a significant contribution here to the improvement of the long-term quality of life of survivors."

The Chief Scientific Officer of the Mainz University Medical Center, Professor Ulrich Förstermann, emphasized that this project again demonstrates the significance assigned to epidemiological research at Mainz. "The University Medical Center with all its institutions is a key player in analyzing the emergence of diseases with their temporal and regional variations in a population, in exploring their development mechanisms, finding causes, preventing late complications, and initiating the corresponding preventative measures."

The German Childhood Cancer Registry has documented all cases of cancer occurring in children and adolescents in Germany since 1980. Some 50,000 cases have been recorded to date and more than 30,000 former patients are in long-term follow-up. The German Childhood Cancer Registry has been asked to act as coordinator for PanCareLIFE, a multinational research project initiated by the European Commission, due to its extensive experience with childhood cancer registration, familiarity with research into the causes and late complications of childhood cancer, and its international links with other institutions.

Contact
PD Dr. Peter Kaatsch, Institute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI), Mainz University Medical Center
phone +49 6131 17–3111 / fax +49 6131 17-4462
e-mail: peter.kaatsch@unimedizin-mainz.de
Press contact
Oliver Kreft, Press and Public Relations, Mainz University Medical Center
phone +49 6131 17-7428 / fax +49 6131 17-3496
e-mail: pr@unimedizin-mainz.de
About the University Medical Center of Johannes Gutenberg University Mainz
The University Medical Center of Johannes Gutenberg University Mainz is the only facility of its kind in Rhineland-Palatinate. It consists of more than 60 clinics, institutes, and departments. Research and teaching are inextricably linked with medical treatment. Approximately 3,500 students of medicine and dentistry are trained in Mainz on a continuous basis. More information can be found at http://www.unimedizin-mainz.de/index.php?L=1

Petra Giegerich | idw
Further information:
http://www.unimedizin-mainz.de/index.php?L=1

More articles from Health and Medicine:

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

nachricht The gut microbiota plays a key role in treatment with classic diabetes medication
01.06.2017 | University of Gothenburg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

Im Focus: Optoelectronic Inline Measurement – Accurate to the Nanometer

Germany counts high-precision manufacturing processes among its advantages as a location. It’s not just the aerospace and automotive industries that require almost waste-free, high-precision manufacturing to provide an efficient way of testing the shape and orientation tolerances of products. Since current inline measurement technology not yet provides the required accuracy, the Fraunhofer Institute for Laser Technology ILT is collaborating with four renowned industry partners in the INSPIRE project to develop inline sensors with a new accuracy class. Funded by the German Federal Ministry of Education and Research (BMBF), the project is scheduled to run until the end of 2019.

New Manufacturing Technologies for New Products

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

A new technique isolates neuronal activity during memory consolidation

22.06.2017 | Life Sciences

Plant inspiration could lead to flexible electronics

22.06.2017 | Materials Sciences

A rhodium-based catalyst for making organosilicon using less precious metal

22.06.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>